An 8-week Full Face HUT Clinical Trial for HydroBoost (2.0/3.0)
An 8-week Full Face HUT Design, Single Center, Double Blinded, Controlled and Randomized Study to Evaluate Different Product Regimens' Performance on Protecting Skin With Resilience Under Tracked City Environmental Aggressors
1 other identifier
interventional
122
1 country
1
Brief Summary
- To investigate the product regiments' performance on moisturization related skin healthy signs (skin moisturization, barrier function, elasticity, translucency, roughness and skin conditions) through instrumental evaluation, clinical grading and self-assessment before, during and after 8 weeks' home usage under city environmental aggressors (Sun, change of temperature and humidity, wind and air pollution) among 3 product regimens and Non-treatment control;
- To explore the linkage among products efficacy, ambient aggressors, and life habits;
- To investigate product regimens' tolerance and safety via Home Use Test;
- To collect skin microflora/microbiome samples for potential research on skin microbiome distribution change as impacted by product application and/or environmental aggressors change (data will be analyzed and reported separately).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 18, 2017
CompletedFirst Submitted
Initial submission to the registry
July 24, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 25, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
July 25, 2017
CompletedFirst Posted
Study publicly available on registry
August 29, 2017
CompletedApril 11, 2018
April 1, 2018
2 months
July 24, 2017
April 10, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Skin surface moisture content
Skin surface moisture content is measured by skin capacitance measurement.
9 weeks
Secondary Outcomes (22)
Quality of Life
9 weeks
Subject Self-assessment
9 weeks
Temperature
9 weeks
Humidity
9 weeks
PM 2.5
9 weeks
- +17 more secondary outcomes
Study Arms (3)
Group 1
EXPERIMENTALNTG Hydro Boost Gelee Milk Cleanser + NTG Hydro Boost Kiwi Water Gel
Group 2
EXPERIMENTALNTG Hydro Boost Gelee Milk Cleanser + NTG Hydro Boost Water Gel
Group 3
EXPERIMENTALNTG Hydro Boost Gelee Milk Cleanser + NTG Hydro Boost Extra Dry Emulsion
Interventions
NTG Hydro Boost Gelee Milk Cleanser + NTG Hydro Boost Kiwi Water Gel
NTG Hydro Boost Gelee Milk Cleanser + NTG Hydro Boost Water Gel
NTG Hydro Boost Gelee Milk Cleanser + NTG Hydro Boost Extra Dry Emulsion
Eligibility Criteria
You may qualify if:
- Chinese Females aged 18 - 40 years old in good physical and mental condition;
- Self-perceived dry facial skin without lesions. Corneometer score ≤35 arbitrary units on both sides of cheek areas;
- Having daily routine skin exposure (out-door activities) to city environmental challenge and having concern on its impact to healthy skin signs (e.g. Smoothness, Firmness, Translucency, Trouble (pimple, acne) free, Plumpness, etc.);
- Willing to stay in Shanghai City during the whole study period without travel plan;
- Having mild to moderate pre-aging sign, e.g. fine line, roughness when skin is dry. Having skin dullness concern on the face;
- Non-regular body moisturizer user. Expose the upper-chest site during study;
- Willing to comply with the study instruction (see Appendix IX);
- Agree to use only water to wash face and upper chest, avoid using any cosmetic products (include but not limited to: wash/ soap/ moisturizer/ toner/ sparge/ sunscreen/ oil/ (water) mask/ scrub/ makeup/ fragrance/ light treatment/ massage, etc.) in the evening before each visit day. No washing on face and upper chest and no product application at home in the morning of the visit day. Subjects will wash the test areas when arrive the test site according to the site instruction;
- After enrollment, there will be a 3-day wash-in period, during which subjects agree to use water only to wash the face and upper chest twice per day in the morning and evening. Avoid using any cosmetic products as listed in above item 8 in both test areas;
- Then an 8-week home use period will follow, during which subjects agree to use the assigned product regimens (facial cleanser and facial cream) on face twice per day in the morning and evening. Use water only to wash the upper chest twice per day in the morning and evening. Avoid using any cosmetic products as listed in above item 8 in both test areas;
- After the 8-week home use of the assigned product regimens, subjects will stop using the products for 3 days (Regression period). Subjects agree to use water only to wash the face and upper chest twice per day in the morning and evening during the period. Avoid using any cosmetic products as listed in above item 8 in both test areas;
- Generally in good health based on medical history reported by the subject;
- Female subjects must meet one of the following criteria:
- Is not of child-bearing potential or is in a monogamous relationship with a partner who is not of child-bearing potential, meaning the subject and/or partner:
- Is post-menopausal (amenorrhea for at least 1 year),
- +9 more criteria
You may not qualify if:
- Participated in any cosmetic clinical test involving facial and/or body product application within 3 months before enrollment.
- Has known allergies or adverse reactions to common topical skincare products;
- Presents with a skin condition that may influence the outcome of the study (e.g., psoriasis, eczema, melanomas), primary/secondary lesions on test sites (e.g. erythema, scars, ulcers, vesicles);
- Has a self-reported uncontrolled metabolic condition or disease, such as diabetes, hypertension, hyper/hypothyroidism, hypercholesterolemia, asthma, epilepsy, etc. Individuals with a controlled health condition may also be excluded from the study at the discretion of the PI, if medically qualified, or the designated study physician;
- Has a history of or concurrent health condition/situation which, in the opinion of the PI, if medically qualified, or the designated study physician, may put the individual at significant risk, confound the study results, or interfere significantly with the individual's participation in the study;
- Is simultaneously participating in any other type of clinical study;
- Is an employee/contractor or immediate family member of the PI, Study Site staff or Sponsor.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Johnson & Johnson Pte Ltdlead
- Shanghai Skin Disease Hospitalcollaborator
- Shanghai China-Norm Management Consulting co.,LTDcollaborator
Study Sites (1)
Shanghai Skin Disease Hospital
Shanghai, Shanghai Municipality, 200443, China
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Chao Yuan
Shanghai Skin Disease Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Since this will be a blind study, the product randomization codes will be generated by study team member different from Study Manager, Study Director, Principle Investigator and any data producers or influencer. The product randomization codes and the corresponding product information (i.e. product name, formula number, batch number, manufacturing/expiry date, etc.) will be sealed in an envelope and before study filed work complete kept by PI until there is a unblinding needs due to medical emergency or report drafting. In this study, in total 4 IPs include 3 facial creams and 1 facial cleanser will be evaluated. Subjects will be assigned to 3 groups randomly and evenly with different facial product regimens (one cleanser + one cream). The product regimens will be applied on the whole face for on-site study and the 8-week HUT. For each subject, left or right cheek area will be randomly chosen as experimental area for evaluation and middle upper chest will be the untreated control area
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 24, 2017
First Posted
August 29, 2017
Study Start
May 18, 2017
Primary Completion
July 25, 2017
Study Completion
July 25, 2017
Last Updated
April 11, 2018
Record last verified: 2018-04
Data Sharing
- IPD Sharing
- Will not share